FindTrial
Sign In

Incidence and risk factor of tenaculum use during endometrial sampling procedure

Incidence and risk factor of tenaculum use during endometrial sampling procedure - Tenaculum use in endometrial sampling

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400079649
Enrollment
Unknown
Registered
2024-01-08
Start date
2024-01-08
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal uterine bleeding

Interventions

Observation group :None

Sponsors

Khon Kaen university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who have the indication for endometrial sampling for diagnosis

Exclusion criteria

Exclusion criteria: - The patients who were diagnosed chronic inflammation disease, Coagulopathy, SLE, HIV, Chronic hepatitis and connective tissue disease. - The patients who used Cytotec before performing the intervention. - The patients who had the history of failure endometrial sampling by using Pipette. - The patients who had the history of radiation therapy. - The patients who recieved the pain control medication before intervention.

Design outcomes

Primary

MeasureTime frame
Incidence of tenaculum use during endometrial sampling procedure;—

Countries

Thailand

Contacts

Public ContactJirawan Thassapong

Khon Kaen university

Jithas@kku.ac.th+66 91 065 8356

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026